ユニオンツール announced plans to construct the Mitsuke No. 4 Plant and acquire land for a new plant. FRONTEO was selected for the Tokyo Metropolitan Government's support program for mid-sized companies, Next Edge Tokyo, and will proceed with expanding its AI drug discovery support platform.
ユニオンツール announced that it will construct the Mitsuke No. 4 Plant, with plans to establish a production and development base to increase production capacity and support business expansion. In addition, the company said it is preparing an application under a regional economy-driving business plan to acquire land for a new plant in Sekiharamachi, Nagaoka, Niigata Prefecture.
FRONTEO announced that it had been selected for the Tokyo Metropolitan Government's support program for mid-sized company growth, Next Edge Tokyo. The company outlined a policy of expanding its AI drug discovery support service, Drug Discovery AI Factory, by strengthening its AI analysis capabilities and expanding joint research through the use of its research facilities.
The view has been expressed that the positive impact on the share prices will be limited, and the announcements are not expected to become major drivers of short-term price movements in either stock.